SRZN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Surrozen Inc (SRZN) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the technical indicators show some bullish momentum, the lack of significant trading trends, poor financial performance in the latest quarter, and absence of strong positive catalysts suggest that holding off on investment may be prudent until further clarity or improvement in fundamentals.
The MACD is above 0 and positively contracting, indicating mild bullish momentum. RSI is neutral at 52.232, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at 27.482 and 28.523, while support levels are at 24.113 and 23.072.
Cantor Fitzgerald initiated coverage with an Overweight rating and a $40 price target, citing leadership in Wnt biology and potential in retinal disease markets. Gross margin remained at 100%.
Net income remains negative at -71.64M, despite an improvement. EPS is still negative at -8.
No recent congress trading data or significant insider/hedge fund activity. News regarding stock options granted to a new employee does not indicate a strong market-moving event.
In Q3 2025, revenue dropped sharply by -90.17% YoY to $983,000. Net income improved but remains negative at -71.64M. EPS increased but is still negative at -8.36. Gross margin stayed flat at 100%.
Cantor Fitzgerald initiated coverage with an Overweight rating and a $40 price target, citing leadership in Wnt biology and potential in retinal disease markets. However, there is no additional analyst consensus or recent updates.
